JP2016519138A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519138A5 JP2016519138A5 JP2016512345A JP2016512345A JP2016519138A5 JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5 JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- protein
- tafa4
- seq
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305592.1 | 2013-05-06 | ||
| EP13305592.1A EP2801369A1 (en) | 2013-05-06 | 2013-05-06 | TAFA4 compounds and uses thereof for treating pain |
| PCT/EP2014/059247 WO2014180853A1 (en) | 2013-05-06 | 2014-05-06 | Tafa4 compounds and uses thereof for treating pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519138A JP2016519138A (ja) | 2016-06-30 |
| JP2016519138A5 true JP2016519138A5 (enExample) | 2018-08-30 |
| JP6487419B2 JP6487419B2 (ja) | 2019-03-20 |
Family
ID=48428409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016512345A Active JP6487419B2 (ja) | 2013-05-06 | 2014-05-06 | Ｔａｆａ４化合物及び疼痛を処置するためのその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9884088B2 (enExample) |
| EP (2) | EP2801369A1 (enExample) |
| JP (1) | JP6487419B2 (enExample) |
| CN (1) | CN105209056B (enExample) |
| CA (2) | CA2910652C (enExample) |
| DK (1) | DK2994157T3 (enExample) |
| ES (1) | ES2813629T3 (enExample) |
| WO (1) | WO2014180853A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107430121B (zh) * | 2015-03-13 | 2020-06-23 | 希森美康株式会社 | 受试物质的检测方法及在该方法中使用的试剂盒 |
| CN111683592B (zh) * | 2017-10-30 | 2023-11-03 | 加利福尼亚大学董事会 | 使用电化学传感器对分析物进行无校正的体内测量 |
| KR102866162B1 (ko) * | 2018-04-24 | 2025-10-01 | 주식회사 뉴라클사이언스 | 신경병성 통증의 치료를 위한 서열 유사성 19, 멤버 a5 항체를 갖는 항-패밀리의 용도 |
| ES2943136T3 (es) * | 2018-09-27 | 2023-06-09 | Inst Nat Sante Rech Med | Polipéptido de TAFA4 para su uso para reducir la inflamación cutánea |
| CN109596818B (zh) * | 2018-12-13 | 2024-03-19 | 丁蓉 | 一种基于电生理学分析当归四逆汤预防奥沙利铂神经毒性机制的研究方法 |
| WO2021156310A1 (en) * | 2020-02-04 | 2021-08-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tafa4 polypeptide or polynucleotide for treating inflammatory disease |
| JP7729824B2 (ja) * | 2020-02-13 | 2025-08-26 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ | マルガリン酸はｐｉｅｚｏ２媒介性疼痛を低減させる |
| TWI759788B (zh) * | 2020-07-08 | 2022-04-01 | 台灣粒線體應用技術股份有限公司 | 萃取保護液用於自細胞分離粒線體並維持粒線體活性的用途 |
| CA3239578A1 (en) | 2021-12-17 | 2023-06-22 | Stephane GAILLARD | Peptides and methods for use in treating pain |
| MX2024007794A (es) * | 2021-12-20 | 2024-07-02 | Amgen Inc | Peptidos de union a dll3 y usos de los mismos. |
| EP4499163A1 (en) * | 2022-03-24 | 2025-02-05 | Baxter International Inc. | Dialysis system having thermoelectric heating |
| AR129441A1 (es) | 2022-05-25 | 2024-08-28 | Tafalgie Therapeutics | Péptidos y métodos para el tratamiento del dolor |
| AU2023278710A1 (en) * | 2022-05-31 | 2024-12-12 | Elisigen Inc. | Composition for treating retinal or macular diseases |
| CN120813839A (zh) | 2023-02-17 | 2025-10-17 | Naos生命科学研究所 | 一种用于筛选能够提高皮肤耐受阈值的生态生物型化合物的方法 |
| WO2025116606A1 (ko) * | 2023-11-30 | 2025-06-05 | 주식회사 뉴라클제네틱스 | 신규한 케모카인-유사 단백질 단편 |
| WO2026119983A1 (en) | 2024-12-03 | 2026-06-11 | Tafalgie Therapeutics | Peptides for use in treating pain, wounds and inflammatory diseases |
| CN121249875B (zh) * | 2025-10-13 | 2026-03-20 | 上海交通大学医学院附属仁济医院 | 外周神经系统中的Mas相关G蛋白耦联受体D在缓解阿片类药物耐受中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090077680A1 (en) * | 2000-06-12 | 2009-03-19 | Alejandro Abuin | Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same |
| WO2006013462A2 (en) * | 2004-07-30 | 2006-02-09 | Nsgene A/S | Growth factors nsg28, nsg30, and nsg32 |
-
2013
- 2013-05-06 EP EP13305592.1A patent/EP2801369A1/en not_active Withdrawn
-
2014
- 2014-05-06 WO PCT/EP2014/059247 patent/WO2014180853A1/en not_active Ceased
- 2014-05-06 JP JP2016512345A patent/JP6487419B2/ja active Active
- 2014-05-06 CN CN201480025716.5A patent/CN105209056B/zh active Active
- 2014-05-06 DK DK14723045.2T patent/DK2994157T3/da active
- 2014-05-06 ES ES14723045T patent/ES2813629T3/es active Active
- 2014-05-06 CA CA2910652A patent/CA2910652C/en active Active
- 2014-05-06 CA CA3235916A patent/CA3235916A1/en active Pending
- 2014-05-06 US US14/787,483 patent/US9884088B2/en active Active
- 2014-05-06 EP EP14723045.2A patent/EP2994157B1/en active Active
-
2017
- 2017-12-14 US US15/841,342 patent/US20180110829A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7379428B2 (ja) | Ｎｋ細胞におけるサイトカイン誘導性ｓｈ２タンパク質の阻害 | |
| EP3371207B1 (en) | Nucleic acids, peptides and methods | |
| Baker et al. | An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders | |
| Park et al. | Molecular cloning and functional analysis of nucleotide-binding oligomerization domain 1 (NOD1) in olive flounder, Paralichthys olivaceus | |
| Rothenburg et al. | Double-stranded RNA-activated protein kinase PKR of fishes and amphibians: varying the number of double-stranded RNA binding domains and lineage-specific duplications | |
| US20160025745A1 (en) | Methods of diagnosing and treating fibrosis | |
| JP2019500414A5 (enExample) | ||
| JP2017213006A5 (enExample) | ||
| JP2015522264A5 (enExample) | ||
| JP2017533910A5 (enExample) | ||
| CN105209056A (zh) | Tafa4化合物及其用于治疗疼痛的用途 | |
| US11931402B2 (en) | Compositions for treating heart disease by inhibiting the action of mAKAP-β | |
| WO2019144053A1 (en) | Gdf11 variants and uses thereof | |
| Hu et al. | Interferon regulatory factor 3 (IRF-3) in Japanese flounder, Paralichthys olivaceus: sequencing, limited tissue distribution, inducible expression and induction of fish type I interferon promoter | |
| US20250250631A1 (en) | Kelch Domain Containing 7B (KLHDC7B) Variants And Uses Thereof | |
| WO2019010301A1 (en) | TREATMENT OF CARDIOPATHIES BY INHIBITING THE ACTION OF PROTEINS FROM ANCHORING TO MUSCLE PROTEIN KINASES A (MAKAP) | |
| US20100266579A1 (en) | Treatment of inflammatory diseases | |
| US20060154886A1 (en) | Regulatory elements in the 5' region of the VR1 gene | |
| JP5793188B2 (ja) | 自己免疫疾患治療及び予防薬としてのｃｔｒｐ６ | |
| Oliveira Filho et al. | Cloning, sequencing and expression analysis of the equine hepcidin gene by real-time PCR | |
| Xiao et al. | Cloning of common carp SOCS-3 gene and its expression during embryogenesis, GH-transgene and viral infection | |
| EP4305167A1 (en) | Immune enhancers | |
| Atianand et al. | Recent evolution of the NF-κB and inflammasome regulating protein POP2 in primates | |
| CN112153897B (zh) | 用于治疗神经病学和其他病症的组合物和方法 | |
| DK2536747T3 (en) | POLYNUCLEOTIDE USED FOR THE TREATMENT OF INFLUENZA A VIRUS-INDUCED DISEASES AND CODING MODIFIED MX PROTEIN, THE MODIFIED MODIFIED MX PROTEIN, AND A TRANSGENT ANIMATED DRIVE, AS AN EXTENDED ANIMALS, AS AN EXTERNAL DRIVE, AS AN EXTENDED ANIMALS |